Literature DB >> 8933366

Evidence for multiple opioid receptors in the human posterior pituitary.

D Jordan1, J A Tafani, C Ries, J M Zajac, G Simonnet, D Martin, N Kopp, M Allard.   

Abstract

The distribution and quantification of opioid receptor types in post-mortem human pituitary cryostat sections was determined by quantitative in vitro receptor autoradiography. Highly specific radioligands were used for each opioid receptor type i.e. [125l]-FK-33-824 for mu-opioid sites, [125l][D.Ala2]-Deltorphin-l for delta-opioid sites and 3H-U69,593 for kappa-opioid sites. None of the five specimens tested exhibited any labeling in the anterior lobe of the pituitary for the three radioligands. As for the posterior pituitary, all 5 specimens contained both mu and kappa-opioid binding sites whereas none of them showed delta-binding sites. The presence of both mu- and kappa-opioid binding sites in the human posterior pituitary contrasts with previous findings in the rat where only kappa-sites have been found. The present study could contribute to understanding of the functional action of opioids in the human pituitary.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8933366     DOI: 10.1046/j.1365-2826.1996.53210.x

Source DB:  PubMed          Journal:  J Neuroendocrinol        ISSN: 0953-8194            Impact factor:   3.627


  2 in total

Review 1.  Opioid-Induced Androgen Deficiency (OPIAD): Diagnosis, Management, and Literature Review.

Authors:  Timothy K O'Rourke; Matthew S Wosnitzer
Journal:  Curr Urol Rep       Date:  2016-10       Impact factor: 3.092

2.  Increased rewarding properties of morphine in dopamine-transporter knockout mice.

Authors:  C Spielewoy; F Gonon; C Roubert; V Fauchey; M Jaber; M G Caron; B P Roques; M Hamon; C Betancur; R Maldonado; B Giros
Journal:  Eur J Neurosci       Date:  2000-05       Impact factor: 3.386

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.